EVOGENE LTD.

EVGNNASDAQ • USD
ThemeFood & Agriculture›Crop Science & Agricultural Inputs
0.62 USD
↗ 0.01 (1.53%)AT CLOSE (11:59 AM EDT)
0.59
↘ 0.03 (4.36%)
POST MARKET (AS OF 07:26 PM EDT)
Post Market
AS OF 07:26 PM EDT
0.59
↘ 0.03 (4.36%)
🔴Market: CLOSED
Open?$0.58
High?$0.64
Low?$0.58
Prev. Close?$0.61
Volume?390.5K
Avg. Volume?940.1K
VWAP?$0.61
Rel. Volume?0.42x
Bid / Ask
Bid?$0.52 × 100
Ask?$0.71 × 100
Spread?$0.20
Midpoint?$0.61
Valuation & Ratios
Market Cap?6.4M
Shares Out?N/A
Float?8.6M
Float %?99.0%
P/E Ratio?N/A
P/B Ratio?0.06
EPS?-$1.65
Dividend?0.00%
Ex-Dividend?N/A

EVOGENE LTD. (EVGN) is currently trading at $0.60. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, EVGN appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

RelatedCARM
News
Profile
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
Themes
Food & Agriculture›Crop Science & Agricultural InputsAI & Machine Learning›AI-Powered Analytics & Decision SystemsBiotech - Drug Development›Clinical-Stage Platforms
Employees
52
Market Cap
6.2M
Industry
N/A
Website
www.evogene.com
Listed
2008-03-05
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
84
Piotroski F-Score?0/9Weak
Altman Z-Score?-41.15Distress
Confidence?33%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.79%Low
Short Interest?154.6K
Days to Cover?3.0
Free Float8.6M
Avg Daily Volume52.0K
Settlement Date2026-05-15
Financial Health
Current Ratio?17.67Strong
Quick Ratio?17.67Strong
Cash Ratio?0.87Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
0.06CHEAP▾
P/S?
S&P
94
0.61CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.1CHEAP▾
EV/Sales?
S&P
97
0.23CHEAP▾
Returns & Efficiency
ROE?
S&P
8
-17.0%WEAK▾
ROA?
Peers
50
S&P
3
-15.8%WEAK▾
Cash Flow & Enterprise
FCF?$-13724000
Enterprise Value?$2.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist